Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schenk

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Anaesthesia, Critical Care & Pain Medicine|November 12, 2025
Macrophage Activation-Like Syndrome in critically ill patients with sepsis: high risk patients with high mortalityFriederike S Schuster, Clarissa von Haefen, Jana Ihlow, et al.
Blood|December 19, 2018
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trialUlrich Jäger, Shirley D'Sa, Christian Schörgenhofer, et al.
European Journal of Haematology|February 18, 2024
Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patientsPeter Nyvlt, Friederike S Schuster, Jana Ihlow, et al.
Leukemia|July 28, 2022
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemiaLioba Schönfeld, Jenny Rinke, Anna Hinze, et al.
Leukemia|December 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspectivePhilipp Ernst, Cera Lohse, Michael Lauseker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2020
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registrySebastian Birndt, Thomas Schenk, Babett Heinevetter, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2019
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)Susanne Möbius, Thomas Schenk, Danny Himsel, et al.
BMJ Open|November 1, 2019
Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocolGunnar Lachmann, Cornelia Knaak, Clarissa von Haefen, et al.
World Neurosurgery|January 9, 2013
Subarachnoid Hemorrhage International Trialists data repository (SAHIT)R Loch Macdonald, Michael D Cusimano, Nima Etminan, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Anaesthesia, Critical Care & Pain Medicine|November 12, 2025
Macrophage Activation-Like Syndrome in critically ill patients with sepsis: high risk patients with high mortalityFriederike S Schuster, Clarissa von Haefen, Jana Ihlow, et al.
Blood|December 19, 2018
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trialUlrich Jäger, Shirley D'Sa, Christian Schörgenhofer, et al.
European Journal of Haematology|February 18, 2024
Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patientsPeter Nyvlt, Friederike S Schuster, Jana Ihlow, et al.
Leukemia|July 28, 2022
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemiaLioba Schönfeld, Jenny Rinke, Anna Hinze, et al.
Leukemia|December 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspectivePhilipp Ernst, Cera Lohse, Michael Lauseker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2020
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registrySebastian Birndt, Thomas Schenk, Babett Heinevetter, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2019
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)Susanne Möbius, Thomas Schenk, Danny Himsel, et al.
BMJ Open|November 1, 2019
Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocolGunnar Lachmann, Cornelia Knaak, Clarissa von Haefen, et al.
World Neurosurgery|January 9, 2013
Subarachnoid Hemorrhage International Trialists data repository (SAHIT)R Loch Macdonald, Michael D Cusimano, Nima Etminan, et al.
Pageof 16